Biofrontera Warrants Stock Profit Margin
BFRIW Stock | USD 0.06 0 1.69% |
Biofrontera Warrants fundamentals help investors to digest information that contributes to Biofrontera Warrants' financial success or failures. It also enables traders to predict the movement of Biofrontera Stock. The fundamental analysis module provides a way to measure Biofrontera Warrants' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofrontera Warrants stock.
Last Reported | Projected for Next Year | ||
Net Loss | (0.59) | (0.62) |
Biofrontera | Profit Margin |
Biofrontera Warrants Company Profit Margin Analysis
Biofrontera Warrants' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Biofrontera Warrants Profit Margin | (0.38) % |
Most of Biofrontera Warrants' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biofrontera Warrants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biofrontera Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Biofrontera Warrants is extremely important. It helps to project a fair market value of Biofrontera Stock properly, considering its historical fundamentals such as Profit Margin. Since Biofrontera Warrants' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biofrontera Warrants' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biofrontera Warrants' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Biofrontera Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Biofrontera Warrants has a Profit Margin of -0.3834%. This is 96.58% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 69.81% lower than that of the firm.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
Biofrontera Fundamentals
Return On Equity | -1.49 | ||||
Return On Asset | -0.4 | ||||
Profit Margin | (0.38) % | ||||
Operating Margin | (0.65) % | ||||
Number Of Shares Shorted | 2.77 K | ||||
Revenue | 34.07 M | ||||
EBITDA | (18.45 M) | ||||
Net Income | (20.13 M) | ||||
Total Debt | 5.4 M | ||||
Book Value Per Share | 3.16 X | ||||
Cash Flow From Operations | (24.89 M) | ||||
Earnings Per Share | (1.30) X | ||||
Number Of Employees | 83 | ||||
Beta | 0.51 | ||||
Total Asset | 27.93 M | ||||
Retained Earnings | (99.65 M) | ||||
Working Capital | 4.99 M | ||||
Net Asset | 27.93 M |
About Biofrontera Warrants Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biofrontera Warrants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofrontera Warrants using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofrontera Warrants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.